Julius Clinical
Marcel van Willigen has extensive experience in clinical data management, project management, and RBQM implementation. Marcel has worked on Phase II, III, and RWE clinical projects and has experience in mentoring new hires. Marcel also has a background in biochemistry and molecular biology, with a Ph.D. in the field. Prior to their current role, Marcel worked as a research technician and completed internships focused on viral vectors and veterinary pharmacology.
This person is not in the org chart
Julius Clinical
At Julius Clinical, science is the foundation. Combined with flexibility, creativity, and innovation, our scientific approach enables fast, efficient, and high quality execution of complex clinical development programs. Our skilled and loyal networks of investigators all around the world allow us to offer superior recruitment in therapeutic area’s such as cardiology, diabetes, CNS and infectious diseases. Our partners include leading pharmaceutical, biotech, medical device, and food companies, as well as academic investigators. We focus on clinical trials that are likely to have a major impact on medicine and on people’s lives. This type of demanding research requires more than a ‘one-size-fits-all’ approach, and our fusion of scientific and operational expertise enables to deliver results efficiently, on time and budget. Julius Clinical has on its staff internationally recognised academic leaders who are actively involved in the design, conduct, and interpretation of clinical trials. This scientific expertise and credibility, combined with personal links with peers around the world, means that the company has a truly global reach and reputation. Through our global networks we can quickly select the most appropriate and high-performing sites to take part in a trial, and ensure that investigators are inspired and motivated.